-
Beyond the blood-brain barrier: HIV research at Texas Biomed gets NIH funding boost
The $3.9 million grant supports research exploring how gene-editing technology may help eradicate HIV in the brain. SAN ANTONIO (July 27, 2022) ā Finding a cure for HIV has been…
-
Starting antiretroviral therapy early essential to battling not one, but two killers
Medication against the nonhuman primate version of HIV given two weeks after infection helped keep tuberculosis in check.
-
Initial COVID-19 infection on the single-cell level, revealed
Sequencing more than 170,000 single cells from animal models have provided exceptionally detailed insight into the early immune response to SARS-CoV-2 in the lungs. The findings will help inform futureā¦
-
Zika vaccine shows promising results in preclinical studies
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies, according to a new studyā¦
-
Texas Biomed breaks ground on new Animal Care Complex
The complex will provide brand new indoor/outdoor housing for up to 800 nonhuman primates and advanced veterinary care capabilities.
-
Compound shows promise for minimizing erratic movements in Parkinsonās patients
Erratic, involuntary movements often emerge as a side effect of the primary medication used to treat Parkinsonās disease. Now, Texas Biomed researchers and their collaborators have shown a compound can…
